|
|
 | | | |
- close
- close
- close
- close
| Revision as of 17:43, July 10, 2011 (edit) Gejordan - Sr. Director (Talk | contribs) ← Previous diff |
Revision as of 17:50, July 10, 2011 (edit) (undo) Gejordan - Sr. Director (Talk | contribs) (→Trends and Forces) Next diff → |
||
| Line 22: | Line 22: | ||
| [[Image: Elsevier.gif]] | [[Image: Elsevier.gif]] | ||
| + | |||
| + | ===Government=== | ||
| + | |||
| + | Our scientific, technical and medical (STM) primary publications, like those of most of our competitors, are published on a paid | ||
| + | subscription basis. There has been continuous debate in the government, academic and library communities, which are the principal customers for our STM publications, regarding whether such publications should be funded instead through fees charged to authors and from governmental and other subsidies or made | ||
| + | freely available after a period following publication. If these methods of STM publishing are widely adopted or mandated, | ||
| + | it could adversely affect our revenue from paid subscription publications. | ||
| + | We engage extensively with stakeholders in the STM community to better understand their needs and deliver value to them. While we adopt a number of publishing models and continue to experiment, through the principal paid subscription model we encourage the submission of research output by scientists without the penalty of publishing cost. We focus on the integrity and quality of research through the editorial and peer review process; we invest in efficient editorial and distribution platforms and in innovation in platforms and tools to make content and data more accessible and actionable; and we ensure vigilance on plagiarism and the long term preservation of research findings.<ref name=risks>[http://reports.reedelsevier.com/ar10/financial_review/principal-risks/principal-risk-part3.htm Reed Elsevier Annual Report 2010: Principal Risks]</ref> | ||
| ==Competition== | ==Competition== | ||
Revision as of 17:50, July 10, 2011
Reed Elsevier PLC (NYSE: RUK) is a publisher and information provider. The company operates in four segments: Elsevier, comprising scientific, technical and medical publishing; LexisNexis, providing legal, tax, regulatory, risk information and analytics, and business information solutions to professional, business and government customers; Reed Exhibitions, organizing trade exhibitions and conferences; and Reed Business Information, providing information and marketing solutions to business professionals.[1]
Contents |
Business Growth
In 2010, Reed Elsevier's revenues were flat at £6,055 million.[2] The company's adjusted operating profit was lower by 1% at £1,555 million, with adjusted earnings per share down 5% to 43.4 pence.[2] Overall, the company's spend on product development and sales and marketing was offset by cost reductions.[2]
Revenue from LexisNexis grew during the year, with strong growth in the risk business. However, subscription revenues in the legal business continued to reflect the lower levels of law firm activity and employment.[2]
In the risk solutions business, strong growth in the insurance business was supported by high transactional activity in the U.S. auto and property markets.[2] A continuous pipeline of new data and analytics products also drives growth, ranging from helping insurers better assess underwriting risk to reducing cost and improving the effectiveness of the insurers’ workflow.[2]
Reed Exhibitions saw revenue growth from biennial exhibitions and a moderated decline in annual show revenues. The 2010 shows have had growing attendance at the majority of annual events and exhibitor numbers up 4% in the top 50 annual shows.[2] Shows in China, Russia, the Middle East and Brazil, in particular, grew strongly.
Reed Business Information saw growth in data services and online marketing solutions and moderated declines in advertising markets. The sale and closure of the U.S. controlled circulation magazines and certain other titles were completed, together with the sale of clusters of titles in Europe and Asia.[2]
Acquisitions
In 2010 Reed Business Information acquired a majority share in the leading petrochemical and energy information service, CBI China.[2] In February 2011, the company acquired Shanghai Datong Medical Information Technology Co., Ltd.[1]
Trends and Forces
Demise of print publications
Reed Elsevier has seen a significant migration from print products to electronic content and tools over the last ten years, so that print revenues now account for only 25% of revenues
Government
Our scientific, technical and medical (STM) primary publications, like those of most of our competitors, are published on a paid subscription basis. There has been continuous debate in the government, academic and library communities, which are the principal customers for our STM publications, regarding whether such publications should be funded instead through fees charged to authors and from governmental and other subsidies or made freely available after a period following publication. If these methods of STM publishing are widely adopted or mandated, it could adversely affect our revenue from paid subscription publications. We engage extensively with stakeholders in the STM community to better understand their needs and deliver value to them. While we adopt a number of publishing models and continue to experiment, through the principal paid subscription model we encourage the submission of research output by scientists without the penalty of publishing cost. We focus on the integrity and quality of research through the editorial and peer review process; we invest in efficient editorial and distribution platforms and in innovation in platforms and tools to make content and data more accessible and actionable; and we ensure vigilance on plagiarism and the long term preservation of research findings.[3]
Competition
- John Wiley & Sons CL A (JWA)
- McGraw-Hill Companies (MHP)
- Pearson (PSO)
- Scholastic (SCHL)
- News Corporation (NWS)
- Thomson Reuters (TRI)
- Lee Enterprises (LEE)
- Educational Development (EDUC)
References
| |||||||
